Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Critical Role of MicroRNA-34a and MicroRNA-194 in Acute Myeloid Leukemia With CEBPA Mutations

NCT01057199 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01057199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01057199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Critical Role of MicroRNA-34a and MicroRNA-194 in Acute Myeloid Leukemia With CEBPA Mutations
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2010
Enrollment
6 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia